An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer

被引：0
|
作者：
Xin Zhou
Xiaping Wang
Zebo Huang
Lei Xu
Wei Zhu
Ping Liu
机构：
[1] First Affiliated Hospital of Nanjing Medical University,Department of Oncology
[2] Cancer Center of Nanjing Medical University,Key Laboratory of Human Functional Genomics of Jiangsu Province, Clinical Diabetes Centre of Jiangsu Province
[3] Nanjing Medical University,Department of Thoracic Surgery
[4] The Affiliated Jiangning Hospital of Nanjing Medical University,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 33卷
关键词：
Breast cancer; ER status; miRNA signature; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer
    Ruckhaeberle, E.
    Holtrich, U.
    Engels, K.
    Hanker, L.
    Gaetje, R.
    Metzler, D.
    Karn, T.
    Kaufmann, M.
    Rody, A.
    CLIMACTERIC, 2009, 12 (06) : 502 - 513
  • [22] Daily aspirin use is associated with a reduced risk of ER-positive breast cancer
    Nature Clinical Practice Oncology, 2008, 5 (8): : 432 - 432
  • [23] Serum soluble ST2 is associated with ER-positive breast cancer
    Lu, Da-peng
    Zhou, Xiang-yu
    Yao, Lu-tian
    Liu, Cai-gang
    Ma, Wei
    Jin, Feng
    Wu, Yun-fei
    BMC CANCER, 2014, 14
  • [24] Serum soluble ST2 is associated with ER-positive breast cancer
    Da-peng Lu
    Xiang-yu Zhou
    Lu-tian Yao
    Cai-gang Liu
    Wei Ma
    Feng Jin
    Yun-fei Wu
    BMC Cancer, 14
  • [25] Evaluation of the OncoMasTR prognostic signature in postmenopausal women with primary ER-positive breast cancer.
    Sestak, Ivana
    Buus, Richard
    Cuzick, Jack M.
    Barron, Stephen
    Loughman, Tony
    Fender, Bozena
    Ruiz, Cesar Lopez
    Dynoodt, Peter
    Wang, Chan-Ju Angel
    O'Leary, Desmond
    Gallagher, William M.
    Dowsett, Mitchell
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] AgNOR analysis of ER-positive and ER-negative tumor cells in breast cancer
    Guski, E
    Winzer, KJ
    Hufnagl, P
    Günther, L
    Kaufmann, O
    PROCEEDINGS OF THE GERMAN SOCIETY FOR PATHOLOGY 82ND MEETING - 1998: SOFT TISSUE TUMORS, 1998, : 470 - 470
  • [27] AgNOR analysis of ER-positive and ER-negative cells in breast cancer.
    Guski, H
    Winzer, KJ
    Hufnagl, P
    Gunther, L
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1996, 40 (04): : 341 - 341
  • [28] High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer
    Chervoneva, Inna
    Peck, Amy R.
    Sun, Yunguang
    Yi, Misung
    Udhane, Sameer S.
    Langenheim, John F.
    Girondo, Melanie A.
    Jorns, Julie M.
    Chaudhary, Lubna N.
    Kamaraju, Sailaja
    Bergom, Carmen
    Flister, Michael J.
    Hooke, Jeffrey A.
    Kovatich, Albert J.
    Shriver, Craig D.
    Hu, Hai
    Palazzo, Juan P.
    Bibbo, Marluce
    Hyslop, Terry
    Nevalainen, Marja T.
    Pestell, Richard G.
    Fuchs, Serge Y.
    Mitchell, Edith P.
    Rui, Hallgeir
    JCO PRECISION ONCOLOGY, 2023, 7
  • [29] Oxysterol signalling is retained in ER-negative and supressed in ER-positive breast cancer
    Hutchinson, Samantha
    Battaglia, Sebastiano
    Roberg-Larsen, Hanne
    Lianto, Priscilia
    Hughes, Thomas
    Thorne, James
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2020, 79 (OCE2) : E142 - E142
  • [30] FGFR1 Is Associated With Tamoxifen Resistance and Poor Prognosis of ER-Positive Breast Cancers by Suppressing ER Protein Expression
    Lv, Qing
    Guan, Shiming
    Zhu, Mingjie
    Huang, Hu
    Wu, Junqiang
    Dai, Xiaofeng
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
12345